Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Rigopoulos

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Biomedicines|February 25, 2023
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic ReviewAikaterini Tsiogka, Stamatios Gregoriou, Alexander Stratigos, et al.
JAMA Dermatology|November 19, 2015
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical TrialVassiliki Tzanetakou, Theodora Kanni, Sophia Giatrakou, et al.
Biomolecules|September 28, 2021
Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army RecruitsIoannis-Alexandros Drosatos, James N Tsoporis, Shehla Izhar, et al.
Journal of Clinical Medicine|February 11, 2023
Dermoscopy of Actinic Keratosis: Is There a True Differentiation between Non-Pigmented and Pigmented Lesions?Dimitrios Sgouros, Melpomeni Theofili, Theodora Zafeiropoulou, et al.
Circulation. Cardiovascular Imaging|September 14, 2017
Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in PsoriasisIgnatios Ikonomidis, Evangelia Papadavid, George Makavos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 20, 2024
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasisNatalia Rompoti, Irene Stefanaki, Pantelis Panagakis, et al.
Dermatology and Therapy|April 26, 2025
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-ADPedro Mendes-Bastos, Elisavet Lazaridou, Tiago Torres, et al.
Experimental Dermatology|October 1, 2014
In situ assessment of PI3K and PTEN alterations in mycosis fungoides: correlation with clinicopathological featuresEvangelia Papadavid, Penelope Korkolopoulou, Georgia Levidou, et al.
The Journal of Dermatological Treatment|January 27, 2025
Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece)Dimitrios Rigopoulos, J Katsantonis, O Neofotistou, et al.
Archives of Dermatological Research|March 29, 2025
Systemic inflammation correlates with depression and lower quality of life in patients with hidradenitis suppurativa independent of disease severityNikolaos Rotsiamis, Natalia Rompoti, Aikaterini Liakou, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Biomedicines|February 25, 2023
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic ReviewAikaterini Tsiogka, Stamatios Gregoriou, Alexander Stratigos, et al.
JAMA Dermatology|November 19, 2015
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical TrialVassiliki Tzanetakou, Theodora Kanni, Sophia Giatrakou, et al.
Biomolecules|September 28, 2021
Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army RecruitsIoannis-Alexandros Drosatos, James N Tsoporis, Shehla Izhar, et al.
Journal of Clinical Medicine|February 11, 2023
Dermoscopy of Actinic Keratosis: Is There a True Differentiation between Non-Pigmented and Pigmented Lesions?Dimitrios Sgouros, Melpomeni Theofili, Theodora Zafeiropoulou, et al.
Circulation. Cardiovascular Imaging|September 14, 2017
Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in PsoriasisIgnatios Ikonomidis, Evangelia Papadavid, George Makavos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 20, 2024
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasisNatalia Rompoti, Irene Stefanaki, Pantelis Panagakis, et al.
Dermatology and Therapy|April 26, 2025
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-ADPedro Mendes-Bastos, Elisavet Lazaridou, Tiago Torres, et al.
Experimental Dermatology|October 1, 2014
In situ assessment of PI3K and PTEN alterations in mycosis fungoides: correlation with clinicopathological featuresEvangelia Papadavid, Penelope Korkolopoulou, Georgia Levidou, et al.
The Journal of Dermatological Treatment|January 27, 2025
Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece)Dimitrios Rigopoulos, J Katsantonis, O Neofotistou, et al.
Archives of Dermatological Research|March 29, 2025
Systemic inflammation correlates with depression and lower quality of life in patients with hidradenitis suppurativa independent of disease severityNikolaos Rotsiamis, Natalia Rompoti, Aikaterini Liakou, et al.
Pageof 14